NOISESaved copy
Coverage history

Assembled by NOISE.

Saved report copy

Recorded

RFK Jr. overrules FDA to allow six peptide sales

Health and Human Services Secretary Robert F. Kennedy Jr. unilaterally issued a rule letting compounding pharmacies sell six unproven peptides, overriding the Food and Drug Administration's safety concerns. The policy, scheduled for publication Oct. 30, covers BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500. The rule follows Kennedy's appointment of eight new FDA advisory panel members, at least six with ties to peptide businesses. Critics say the untested products pose safety risks and could reduce incentives for clinical trials.